1Schwartz PJ,De Ferrari GM.Sympathetic-parasympathetic interaction in health and disease:abnormalities and relevance in heart failure. Heart Fail Reviews . 2011
2Zhang Y,Popovic ZB,Bibevski S,et al.Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail . 2009
3Uthman BM,Reichl AM,Dean JC,et al.Effectiveness of vagus nerve stimulation in epilepsy patients:a12-year observation. Neurology . 2004
4Shuchman M.Approving the vagus-nerve stimulator for depression. The New England Journal of Medicine . 2007
5Klein HU,Ferrari GM.Vagus nerve stimulation:A new approach to reduce heart failure. Cardiol J . 2010
6La Rovere MT,Pinna GD,Maestri R,et al.Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. Journal of the American College of Cardiology . 2009
7Nemeroff CB,Mayberg HS,Krahl SE,et al.VNS therapy in treatment-resistant depression:clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology . 2006
8Schwartz PJ,De Ferrari GM,Sanzo A,et al.Long term vagal stimulation in patients with advanced heart failure:first experience in man. European Journal of Heart Failure . 2008
9De Ferrari GM,Crijns HJ,Borggrefe M,et al.Chronic vagus nerve stimulation:a new and promising therapeutic approach for chronic heart failure. European Heart Journal . 2011
10Kleiger RE,Miller JP,Bigger JT,et al.Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. The American Journal of Cardiology . 1987
2Peter JS,Gaetano MD. Sympathetic-parasympathetic interac- tion in health and disease: abnormalities and relevance in heart failure[J]. Heart Fail Rev,2011,2(16)..101-107.
3Barron HV. Autonomic nervous system and sudden cardiac death[J]. J Am Coll Cardiol, 1996,27(5) .. 1053-1056.
4Brunner-La,Roeca HP,Jennings GL. Effect of cardiac sympa- thetic nervous activity on mode of death in congestive heart failure [J]. Eur Heart J,2001,22(13) :1136-1143.
5Mann DL, Kent RL,Cooper Gt, et al. Adrenergic effects on the biology of the adult mammalian cardiocyte[J]. Circulation, 1992,85(2) : 790-804.
6Fowler MB, Laser JA, Hopkins GL, et al. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response[J]. Circulation,1986,74(6):1290-1302.
7Hare JM,Keaney JF,Balligand JL, et al. Role of nitric oxide in parasympathetic modulation of beta adrenergic myocardial contractility in normal dogs[J]. J Clin Invest , 1995,95 (1) 360-366.
8Vanoli E, Adamson PB. What does the future hold for the management of chronic heart {ailure[J]. Eur Heart J Suppl, 2006,8(1),C51-C57.
9Rzerkt D, Gorska D. Drugs used in cardiovascular diseases and cytokines[J]. Wlad Lek, 2006,59 (3-4) : 232-237.
10Nozawa T,Lgawa A,Fuiii N, et al. effects of long-tern renal sympathetic denervation on heart failure after myocardial in- farction in rats[J] . Heart Vessels ,2002,16(2) :51-56.
